+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Intracranial Stents Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905023
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Intracranial Stents Market is projected to reach USD 3.04 Billion in 2026. It is expected to continue growing at a CAGR of 5.26%, reaching USD 4.15 Billion by 2032.

Intracranial stents are specialized neurovascular implants used to restore vessel patency, support coil embolization, divert blood flow from intracranial aneurysms, and manage selected cases of intracranial atherosclerotic disease. Demand is anchored in the global burden of stroke and cerebrovascular disorders, with the CDC reporting more than 795,000 strokes annually in the United States and ischemic stroke accounting for about 87% of cases.

The intracranial stents landscape is shaped by evidence-based patient selection, rapid neuroimaging, improved microcatheter delivery systems, and growing adoption of flow-diverter and braided stent technologies. Clinical value increasingly depends on procedural safety, vessel compatibility, antiplatelet management, operator experience, and long-term aneurysm occlusion or vessel patency outcomes.

Transformative Shifts in the Intracranial Stents Landscape

The intracranial stents landscape is shifting from broad intervention toward highly selective, imaging-guided therapy. Randomized evidence, including SAMMPRIS, materially changed treatment for symptomatic intracranial stenosis by emphasizing aggressive medical management for many patients, while subsequent registry and post-market data have supported safer outcomes when stenting is restricted to carefully selected, on-label populations treated by experienced operators.

At the same time, aneurysm management is being transformed by flow diversion, low-profile stent-assisted coiling platforms, braided designs, and surface-modified devices intended to reduce thrombogenicity. Hospitals are prioritizing comprehensive stroke center capabilities, multidisciplinary neurointerventional teams, advanced biplane angiography, and device portfolios that address tortuous anatomy, wide-neck aneurysms, and smaller distal vessels.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating measurable workflow advantages across the intracranial stents ecosystem. AI-enabled CT, CTA, MRI, and perfusion imaging tools help accelerate stroke triage, identify large-vessel occlusion, support aneurysm detection, and prioritize time-sensitive neurointerventional cases where minutes influence neurological outcomes.

Beyond diagnosis, AI supports 3D vessel segmentation, device sizing, computational flow modeling, and procedural planning for flow diversion or stent-assisted coiling. For manufacturers and healthcare providers, AI is improving design simulation, manufacturing quality control, case review, complaint analysis, registry management, and post-market surveillance, while regulatory expectations continue to require transparency, validation, cybersecurity, bias assessment, and real-world performance monitoring.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America remains a leading region for intracranial stents due to advanced stroke networks, high neurointerventional procedure volumes, FDA-regulated device pathways, comprehensive stroke center certification, and structured reimbursement coverage in major hospital systems. Europe follows with broad adoption across Germany, France, Italy, Spain, and the United Kingdom, supported by specialized neurovascular centers, mature clinical research activity, public health stroke initiatives, and increasing alignment under EU Medical Device Regulation requirements for clinical evidence and post-market surveillance.

Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia invest in stroke care infrastructure, advanced imaging, specialist training, and local device manufacturing. Latin America shows growing demand in Brazil and Mexico, although access remains concentrated in large urban hospitals with angiography capacity and trained neurointerventional teams. The Middle East, led by GCC health investments, is scaling tertiary neurology, digital health, and medical tourism capacity, while Africa remains underserved but presents long-term clinical need as stroke burden, hypertension prevalence, diagnostic access, and referral pathways continue to evolve.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, adoption is supported by expanding private hospital networks, medical tourism, and gradual deployment of advanced endovascular stroke care in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, although access differs significantly between capital-city hospitals and rural systems. The GCC is investing heavily in tertiary care, digital health, specialist recruitment, and internationally accredited hospitals, creating demand for advanced neurovascular devices in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman.

The European Union provides a large regulated environment with high expectations for clinical evidence, post-market clinical follow-up, unique device identification, traceability, and conformity under the Medical Device Regulation. BRICS economies contribute scale through China, India, Brazil, Russia, and South Africa, with opportunities shaped by domestic manufacturing, public procurement, specialist availability, and reimbursement variability. G7 countries remain technology leaders with mature evidence generation, academic neurovascular centers, and established regulatory oversight, while NATO countries benefit from advanced hospital infrastructure, trauma-neurovascular readiness, and cross-border clinical collaboration across many member states.

Key Country Insights Across Major Intracranial Stents Markets

The United States leads commercialization due to FDA-authorized neurovascular technologies, large comprehensive stroke centers, advanced imaging availability, clinical trial activity, and high procedural capacity, while Canada benefits from centralized specialist care, public health system purchasing, and regional stroke networks. Mexico and Brazil show increasing demand in metropolitan hospitals, driven by private-sector investment and tertiary referral centers, but access remains uneven outside major cities because of specialist shortages, reimbursement limitations, and infrastructure gaps.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support strong adoption through established stroke networks, specialist neurointerventional centers, and guideline-driven care, while Russia’s market is shaped by localization priorities, public procurement, and variable regional access. China is scaling domestic innovation, hospital capacity, and stroke center development; India is expanding private-sector neurointervention and advanced imaging access; Japan benefits from advanced devices, high clinical discipline, and an aging population; Australia has strong tertiary care systems and organized stroke pathways; and South Korea combines high imaging penetration, sophisticated hospital technology adoption, and strong specialist expertise.

Actionable Recommendations for Industry Leaders

Industry leaders should align device development with evidence-based indications, neurovascular anatomy, and real-world operator needs. Priority actions include investing in lower-profile delivery systems, improved radiopacity, controlled deployment, resheathability, vessel-wall apposition, antithrombotic surface technologies, and clinical studies that document safety, patency, aneurysm occlusion, retreatment rates, ischemic events, hemorrhagic complications, and functional outcomes.

Commercial teams should focus on comprehensive stroke centers, physician training, proctoring programs, post-market evidence, and value-based messaging tied to reduced complications, improved procedural efficiency, and durable outcomes. Manufacturers should also strengthen AI-enabled planning partnerships, cybersecurity controls, supply chain resilience, regulatory readiness, registry participation, and country-specific reimbursement strategies to improve access across mature and emerging neurovascular systems.

Research Methodology

This executive summary is based on a structured review of verified secondary sources, including public health statistics from the CDC, WHO, and major stroke associations; regulatory information from agencies such as the FDA and European authorities; peer-reviewed clinical evidence; clinical guidelines; and publicly available hospital, registry, and policy data.

The methodology emphasizes triangulation across epidemiology, clinical outcomes, regulatory pathways, device innovation, regional healthcare infrastructure, reimbursement conditions, and specialist capacity. Insights were assessed for relevance to intracranial stents, flow diversion, stent-assisted coiling, and intracranial atherosclerotic disease treatment, with preference given to validated clinical, regulatory, and institutional sources.

Conclusion

The intracranial stents market is advancing through precision patient selection, safer device engineering, AI-enabled imaging, and expanding neurointerventional capacity. Opportunities are strongest where stroke systems, advanced imaging, trained specialists, referral networks, and reimbursement frameworks converge.

Future leadership will depend on combining clinical evidence with differentiated technology, real-world data, regulatory discipline, and region-specific access strategies. Organizations that demonstrate procedural safety, long-term outcomes, workflow value, and responsible adoption of AI-enabled neurovascular tools will be best positioned in this high-acuity intracranial stents segment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Intracranial Stents Market, by Product Type
7.1. Introduction
7.2. Balloon Expandable
7.3. Self Expanding
7.3.1. Braided
7.3.2. Laser Cut
8. Intracranial Stents Market, by Material
8.1. Introduction
8.2. Cobalt Chromium
8.3. Nickel Titanium
8.4. Stainless Steel
9. Intracranial Stents Market, by Coating
9.1. Introduction
9.2. Bare Metal
9.3. Drug Eluting
9.3.1. Paclitaxel
9.3.2. Sirolimus
10. Intracranial Stents Market, by Indication
10.1. Introduction
10.2. Aneurysm
10.2.1. Fusiform
10.2.2. Saccular
10.3. Stenosis
10.3.1. Atherosclerotic
10.3.2. Thrombotic
11. Intracranial Stents Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
12. Intracranial Stents Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.2.1. E Commerce
12.2.2. Field Force
12.3. Distributor
12.3.1. National Distributors
12.3.2. Regional Distributors
13. Intracranial Stents Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Intracranial Stents Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Intracranial Stents Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Acandis GmbH
17.3. Asahi Intecc Co., Ltd.
17.4. Balt Group
17.5. Boston Scientific Corporation
17.6. Cerus Endovascular Ltd.
17.7. Contego Medical, Inc.
17.8. Cook Medical LLC
17.9. Evasc Neurovascular Enterprises ULC
17.10. Fluid Biomed Inc.
17.11. InspireMD, Inc.
17.12. Johnson & Johnson MedTech
17.13. Kaneka Corporation
17.14. Medtronic plc
17.15. MicroPort Scientific Corporation
17.16. MicroVention, Inc.
17.17. Obex Medical Ltd.
17.18. Oxford Endovascular Ltd.
17.19. Penumbra, Inc.
17.20. Perflow Medical Ltd.
17.21. Phenox GmbH
17.22. Rapid Medical Ltd.
17.23. Stryker Corporation
17.24. Terumo Corporation
17.25. TonBridge Medical Technology Co., Ltd.
17.26. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL INTRACRANIAL STENTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL INTRACRANIAL STENTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL INTRACRANIAL STENTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL INTRACRANIAL STENTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL INTRACRANIAL STENTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
FIGURE 9. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2025 VS 2032 (%)
FIGURE 11. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL INTRACRANIAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL INTRACRANIAL STENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL INTRACRANIAL STENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BALLOON EXPANDABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BALLOON EXPANDABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BALLOON EXPANDABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SELF EXPANDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SELF EXPANDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SELF EXPANDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BRAIDED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BRAIDED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BRAIDED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LASER CUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LASER CUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LASER CUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL COBALT CHROMIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL COBALT CHROMIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL COBALT CHROMIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL NICKEL TITANIUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL NICKEL TITANIUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NICKEL TITANIUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL BARE METAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL BARE METAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BARE METAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG ELUTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG ELUTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG ELUTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PACLITAXEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL PACLITAXEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL PACLITAXEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SIROLIMUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SIROLIMUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SIROLIMUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ANEURYSM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ANEURYSM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ANEURYSM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL FUSIFORM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL FUSIFORM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL FUSIFORM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SACCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SACCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SACCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL STENOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL STENOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL STENOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ATHEROSCLEROTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ATHEROSCLEROTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ATHEROSCLEROTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL THROMBOTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL THROMBOTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL THROMBOTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL E COMMERCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL E COMMERCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL E COMMERCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FIELD FORCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FIELD FORCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL FIELD FORCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DISTRIBUTOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL DISTRIBUTOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL DISTRIBUTOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL NATIONAL DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL NATIONAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL NATIONAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL REGIONAL DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL REGIONAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL REGIONAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 98. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 100. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 101. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 102. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 103. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 104. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 105. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 106. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 107. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 109. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 110. EUROPE INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 137. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 139. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 140. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 141. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 142. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 143. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 144. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 145. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 146. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 149. AFRICA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 158. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. NATO INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. NATO INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 166. NATO INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 167. NATO INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 168. NATO INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 169. NATO INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 170. NATO INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 171. NATO INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 172. NATO INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 173. NATO INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. NATO INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 175. NATO INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 176. NATO INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 177. G7 INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 178. G7 INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 179. G7 INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 180. G7 INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 181. G7 INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 182. G7 INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 183. G7 INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 184. G7 INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 185. G7 INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 186. G7 INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. G7 INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 188. G7 INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 189. G7 INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 190. BRICS INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. BRICS INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. BRICS INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 193. BRICS INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 194. BRICS INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 195. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 196. BRICS INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 197. BRICS INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 198. BRICS INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 199. BRICS INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 201. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 202. BRICS INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 216. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 217. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 218. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 219. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 220. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 221. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 222. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 223. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 224. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 225. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 228. ASEAN INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 229. GCC INTRACRANIAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. GCC INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. GCC INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 232. GCC INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 233. GCC INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 234. GCC INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 235. GCC INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 236. GCC INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 237. GCC INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 238. GCC INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. GCC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. GCC INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 241. GCC INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 242. GLOBAL INTRACRANIAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 243. CHINA INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. CHINA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 245. CHINA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 246. CHINA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 247. CHINA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 248. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 249. CHINA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 250. CHINA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 251. CHINA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 252. CHINA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 254. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 255. CHINA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 256. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 269. JAPAN INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 271. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 272. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 273. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 274. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 275. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 276. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 277. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 278. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 279. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 280. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 281. JAPAN INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 282. INDIA INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 283. INDIA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. INDIA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 285. INDIA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 286. INDIA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 287. INDIA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 288. INDIA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 289. INDIA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 290. INDIA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 291. INDIA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. INDIA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 293. INDIA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 294. INDIA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 295. GERMANY INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 297. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 298. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 299. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 300. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 301. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 302. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 303. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 304. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 307. GERMANY INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 321. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 322. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 323. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 324. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 325. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 326. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 327. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 328. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 329. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 330. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 332. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 333. AUSTRALIA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 334. FRANCE INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 335. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 336. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 337. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 338. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 339. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 340. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 341. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 342. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 343. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 344. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 345. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 346. FRANCE INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 347. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 349. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 350. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 351. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 352. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 353. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 354. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 355. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 356. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 357. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 358. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY DIRECT SALES, 2017-2032 (USD MILLION)
TABLE 359. SOUTH KOREA INTRACRANIAL STENTS MARKET SIZE, BY DISTRIBUTOR, 2017-2032 (USD MILLION)
TABLE 360. ITALY INTRACRANIAL STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 361. ITALY INTRACRANIAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 362. ITALY INTRACRANIAL STENTS MARKET SIZE, BY SELF EXPANDING, 2017-2032 (USD MILLION)
TABLE 363. ITALY INTRACRANIAL STENTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 364. ITALY INTRACRANIAL STENTS MARKET SIZE, BY COATING, 2017-2032 (USD MILLION)
TABLE 365. ITALY INTRACRANIAL STENTS MARKET SIZE, BY DRUG ELUTING, 2017-2032 (USD MILLION)
TABLE 366. ITALY INTRACRANIAL STENTS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 367. ITALY INTRACRANIAL STENTS MARKET SIZE, BY ANEURYSM, 2017-2032 (USD MILLION)
TABLE 368. ITALY INTRACRANIAL STENTS MARKET SIZE, BY STENOSIS, 2017-2032 (USD MILLION)
TABLE 369. ITALY INTRACRANIAL STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • Asahi Intecc Co., Ltd.
  • Balt Group
  • Boston Scientific Corporation
  • Cerus Endovascular Ltd.
  • Contego Medical, Inc.
  • Cook Medical LLC
  • Evasc Neurovascular Enterprises ULC
  • Fluid Biomed Inc.
  • InspireMD, Inc.
  • Johnson & Johnson MedTech
  • Kaneka Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Obex Medical Ltd.
  • Oxford Endovascular Ltd.
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Terumo Corporation
  • TonBridge Medical Technology Co., Ltd.
  • W. L. Gore & Associates, Inc.

Table Information